Tempus xF Flashcards

1
Q

What does ctDNA stand for?

A

Circulating Tumor DNA. Specific to DNA derived from a tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does cfDNA stand for?

A

cell free DNA. DNA freely circulating in the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Are we more interested in ctDNA?

A

Yes, because it’s coming from cells directly impacted by a tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are CTC’s?

A

Circulating tumor cells. Cells that have broken off from the tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

True or false- Liquid biopsy is a type of assay which tests ctDNA and or CTC’s?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain a liquid biopsy test:

A

it’s a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or to look for DNA from tumor cells that are in the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is CTC and ctDNA important clinically?

A
  • screening and early detecting of cancer
  • real-time monitoring of therapy
  • risk for metastatic relapse
  • determine at level we see which mutations and which therapies are most effective
  • determining which therapies are most appropriate and if that patient will have resistance to those therapies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tumor shedding

A

Cells break off from the tumor and “shed” into the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

1.) Tumor invasion

A

may happen when a tumor invades a nearby blood or lymphatic vessel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2.) Necrosis

A

Due to a cell dying. Either due to treatment or naturally being released from the tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3.) Apoptosis

A

Same thing. Cell dying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumor heterogeneity and clonal evolution:

A

different cells in a tumor have different profiles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Minimal residual disease

A

detection of cancer remaining in the body during or following treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clonal hematopoiesis

A

occurs when there is a somatic mutation in a stem cell and that mutation will appear in the blood cells which derived from that stem cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When does this commonly happen?

A

happens naturally with age, but also commonly happens in genes associated with leukemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pro’s

A

Non-invasive
easily repeatable
minimal pain/risk in specimen collection
more comprehensive picture of disease
dynamic monitoring of disease control/resistance
potential to reveal tumor heterogeneity

17
Q

Con’s

A

detection complicated by low concentrations
false negatives are a concern
false positives due to CHIP
quality of sample may be impacted by minor protocol deviations
no RNA analysis, no incidental germline findings.

18
Q

What is Tempus xF?

A

a liquid biopsy test that examines both ctDNA and CTC. Both are analyzed together.

19
Q

Genes analyzed?

A
105 genes (SNV's/indels) 
7 gene rearrangements 
8 copy number gains/losses
20
Q

depth of coverage

A

5,000x (since the DNA is so small, we want to be 100% sure what we are seeing is accurate) *

21
Q

immunotherapy metrics

A

MSI-H only (MSI-High)*

22
Q

specimen requirements

A
  • two streck tubes of peripheral blood (8.5mL)
  • 4-10mL frozen plasma
  • 50ng cfDNA extracted from double-spun plasma
23
Q

Turnaround time

A

10 days from sample received

blood should be received within 72 hours of a draw

24
Q

Not included

A

normal match incidental germline
RNA
TMB
IHC options

25
Q

How it works in the lab?

A

1) peripheral blood sample obtained (streck)
2) centrifuged blood sample to separate out plasma, white blood cells, and platelets/ red blood cells
3) isolate cfDNA from the plasma

26
Q

Streck tube- Centrifuge breakdown

A

Plasma- 55% of total blood
Buffy coat- <1% of total blood
Erythrocytes- 45% of total blood

27
Q

what’s a huge advantage with Tempus vs. competitors:

A

to be able to convert from a solid tumor test to liquid biopsy.

28
Q

Is there RNA in the xF test?

A

No. But we do show big gene rearrangements and fusions that are still detected by just seeing the DNA.

29
Q

Is there normal match with this test?

A

No.

30
Q

Included elements in this test:

A
  • No normal match
  • no MRD
  • No incidental germline
  • No RNA
  • No TMB
31
Q

What’s the point of the xF test

A

To determine what treatment plans are best for the patient. Designed to come up with therapeutic options for a patient with cancer.